NCT02077881 2026-04-03Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic CancerLumos PharmaPhase 1/2 Completed157 enrolled 18 charts
NCT03678883 2026-04-039-ING-41 in Patients With Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT05586516 2026-03-30A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic CanceriOncturaPhase 1/2 Completed16 enrolled